Abstract: A wound therapy system includes a dressing an instillation pump fluidly communicable with the dressing and configured to provide instillation fluid to the dressing, a negative pressure pump fluidly communicable with the dressing and configured to remove air from the dressing, and a control circuit communicably coupled to the instillation pump and the negative pressure pump. The control circuit is configured to control the instillation pump to provide an amount of the instillation fluid to the dressing, provide a soak period, and control the negative pressure pump to provide a cyclic variation of negative pressure at the dressing.

Abstract: A disposable absorbent article may include a chassis that includes a topsheet, a backsheet, and an absorbent core disposed between the topsheet and the backsheet; and a leg gasketing system and a waist gasketing element. The leg gasketing system may include an inner cuff and an outer cuff; the inner cuff may include an inner cuff folded edge and an inner cuff material edge and the outer cuff may include an outer cuff folded edge and an outer cuff material edge such that the web of material is folded laterally inward to form the outer cuff folded edge and folded laterally outward to form the inner cuff folded edge. The leg gasketing system may also include a leg gasketing system pocket with an opening on an inboard longitudinal edge of the pocket.

Abstract: One example method includes receiving information for a shipment, the shipment comprising one or more pieces, the information comprising information about a destination; receiving, from a remote dimensioning device, dimension information, the dimension information providing a length, a width, and a height for each of the one or more pieces; transporting, using one or more first transport vehicles, the shipment to a first shipper facility; allocating, using a first trained machine learning (“ML”) model and the dimension information, each piece of the shipment to one or more second transport vehicles and loading each piece of the shipment according to the allocating, wherein the first trained ML model is trained based on length, width, and height dimension information for one or more pieces; transporting, using the one or more second transport vehicles, the shipment to a second shipper facility; allocating, using a second trained machine learning (“ML”) model and using the dimension information, each piece of t

Abstract: A wound debridement system includes a wound dressing having an active layer and a wound interface layer. The active layer is formed from one or more transmission layers that are arranged about a central post. Activation of the transmission layers is configured to cause the movement of the wound interface layer relative to a tissue site to which the wound dressing is applied. A drive unit is operably attached to the central post. The drive unit is configured to generate and transfer a vibrational energy and/or a rotational movement to the transmission layer(s) via the central post. The resultant vibration and/or rotation of the transmission layer(s) is imparted onto the wound interface layer, thereby effectuating the desired movement of the wound interface layer relative to the tissue site, which allows for the debridement of debris that may be located at the tissue site.

Abstract: A disposable absorbent article may include a chassis that includes a topsheet, a backsheet, and an absorbent core disposed between the topsheet and the backsheet; and a leg gasketing system and a waist gasketing element. The leg gasketing system may include an inner cuff and an outer cuff; the inner cuff may include an inner cuff folded edge and an inner cuff material edge and the outer cuff may include an outer cuff material edge such that the web of material is folded outward to form the inner cuff folded edge. When tested by the Blowout Method Test as described herein, the disposable absorbent article has a Blowout Percent Leakage of less than about 9.0%.

Abstract: An absorbent article includes a first waist region, a second waist region, and a crotch region disposed between the first and second waist regions; and a chassis having a topsheet, a backsheet, and an absorbent core positioned between the topsheet and the backsheet. The article also includes a side panel having an ultrasonically bonded, gathered laminate. The laminate has an elastomeric layer and a substrate and is joined to the chassis at a chassis attachment bond and positioned in one of the first or second waist regions. The ultrasonically bonded, gathered laminate also includes an ear structural feature comprising a surface modification to the substrate and comprising at least one of the following: embossing, apertures, perforations, slits, melted material or coatings, compressed material, secondary bonds that are disposed apart from a chassis attachment bond, plastic deformation, and folds.

Abstract: In one example embodiment, a system for treating a tissue site is disclosed comprising a dressing adapted to contact the tissue site and provide a fluid seal between a therapeutic environment and a local external environment, and a solution source fluidly coupled to the dressing and adapted to deliver an antimicrobial solution comprising a peroxy ?-keto carboxylic acid, such as peroxy pyruvic acid, to the tissue interface. The system may further comprise a negative-pressure source fluidly coupled to the dressing and adapted to provide negative pressure to the therapeutic environment after delivery of the antimicrobial fluid to the therapeutic environment.

Abstract: A wound dressing that includes a contact layer having walls defining a plurality of perforations and a debriding matrix including a polymer and at least one debriding agent is provided herein. Systems, methods and kits using the wound dressing for debriding a tissue site are also provided herein.

Abstract: An apparatus for treating a tissue site comprising a negative-pressure source configured to be fluidly coupled to the tissue site; an instillation source configured to be fluidly coupled to the tissue site; and a controller operatively coupled to the negative-pressure source and to the instillation source. The controller can be configured to operate the negative-pressure source and the instillation source to intermittently deliver negative pressure to the tissue site for a negative-pressure interval and deliver instillation fluid to the tissue site for an instillation interval. A purge volume of instillation fluid may be delivered to the tissue site at a purge frequency. In some examples, the purge volume may be delivered through the second fluid conductor and removed through the first fluid conductor during a negative-pressure interval.

Abstract: A wound therapy system includes an instillation fluid canister configured to contain an instillation fluid, a pump fluidly coupled to the instillation fluid canister and operable to deliver the instillation fluid from the instillation fluid canister to a wound, a user interface configured to receive user input indicating one or more geometric attributes of the wound, and a controller electronically coupled to the pump and the user interface. The controller is configured to determine a volume of the wound based on the user input, determine a volume of the instillation fluid to deliver to the wound based on the volume of the wound, and operate the pump to deliver the determined volume of the instillation fluid to the wound.

Abstract: Disclosed is an air purification device having a housing for holding a photocatalytic oxidation (PCO) unit and a fan assembly. The device may also optionally include a filter compartment for holding a filter such as a HEPA filter. The air purification device is configured to provide effective purification and sanitation of air in a targeted indoor environment, and in particular in a medical environment such as a hospital.

Abstract: A wound therapy system includes an instillation fluid canister configured to contain an instillation fluid, a pump fluidly coupled to the instillation fluid canister and operable to deliver the instillation fluid from the instillation fluid canister to a wound, a user interface configured to receive user input indicating one or more geometric attributes of the wound, and a controller electronically coupled to the pump and the user interface. The controller is configured to determine a volume of the wound based on the user input, determine a volume of the instillation fluid to deliver to the wound based on the volume of the wound, and operate the pump to deliver the determined volume of the instillation fluid to the wound.

Abstract: A wound therapy system includes a therapy unit, a wound dressing and an optional controller. The therapy unit is configured to deliver instillation fluid to a wound site. The wound dressing is formed from a plurality of discrete, individual blocks that are selectively separable from one another along a plurality of separation-lines, allowing the wound dressing to be customized to the shape and size of the wound site. By calculating the remaining blocks that define the wound dressing following customization, the volume of the wound dressing may be determined. The controller may be configured to deliver fluid to the wound site based on this calculated volume. The controller may also optionally be used to gauge the healing of the wound site over time by monitoring the changes in volume of customized wound dressings as wound dressings are replaced during the course of treatment of the wound site.

Abstract: Apparatuses, systems, and methods for treating a tissue site are described. The apparatus includes a dressing for treating a tissue site. The dressing includes a contact layer having a first side and a second side configured to be positioned adjacent to the tissue site. A plurality of holes extend through the contact layer from the first side to the second side. The dressing also includes a retainer layer coupled to the first side of the contact layer.

Abstract: A customizable wound treatment system for treating multiple zones of a wound includes a dressing configured for use with a first zone and a second zone of a wound that includes a first foam layer placed over the first zone, a second foam layer placed over the second zone, a first drape layer disposed over the first foam layer and beneath the second foam layer, and a second drape layer disposed over the second foam layer. The customizable wound treatment system includes a negative pressure source pneumatically coupled to the first foam layer and the second foam layer and operable to create a negative pressure at the first zone and the second zone and a fluid instillation pump fluidly coupled to the first foam layer and configured to instill a treatment fluid to the first zone.

Abstract: A dressing includes a foam layer, a plurality of cores extending substantially through the foam layer, and a drape sealable over the foam layer and a wound bed. The drape is couplable to a pump operable to create a negative pressure in the substantially-airtight volume. Each core is substantially removable from the foam layer to reveal a channel through the foam layer. Each core is defined by perforations that facilitate separation of the core from the foam layer.

Abstract: A releasable connector for a negative pressure wound therapy system having a drape and a tube includes a base and a tube fitting. The base is configured to be coupled to the drape such that a substantially air-tight seal is formed between the base and the drape. The base includes a base locking member. The tube fitting is configured to be coupled to the tube such that a substantially air-tight seal is formed between the tube fitting and the tube. The tube fitting includes a tube locking member. The tube fitting is further configured to be selectively coupled to the base through an interaction between the tube locking member and the base locking member such that a substantially air-tight seal is formed between the tube fitting and the base.

Abstract: In one example embodiment, a system for treating a tissue site is disclosed comprising a dressing adapted to contact the tissue site and provide a fluid seal between a therapeutic environment and a local external environment, and a solution source fluidly coupled to the dressing and adapted to deliver an antimicrobial solution comprising a peroxy ?-keto carboxylic acid, such as peroxy pyruvic acid, to the tissue interface. The system may further comprise a negative-pressure source fluidly coupled to the dressing and adapted to provide negative pressure to the therapeutic environment after delivery of the antimicrobial fluid to the therapeutic environment.